The U.S. FDA has declined to approve Viatris and Mapi Pharma’s once-a-month injection for treating relapsing forms of multiple sclerosis (MS), the companies said on Monday. The companies were reviewing the content of the health regulator’s complete response letter and would… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]
Published on March 11, 2024
Children with “lazy eye” are more likely to become adults facing an array of serious health problems, a new study warns. Kids diagnosed with amblyopia are more likely to develop high blood pressure, obesity and diabetes as adults, researchers found. They also face an… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
Published on March 11, 2024
Smaller class sizes in schools are failing to increase the resilience of children from low-income families, according to a new study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for […]
Published on March 10, 2024